Epilepsy and Seizure Disorders
| Condition(s) | Type of Drug | Phase | Add-On | Placebo | Duration | Open Label Extension |
|---|---|---|---|---|---|---|
| Prolonged Seizures | Oral Spray Alprazolam | III | Yes | 50% | 18 weeks | 4 years |
| Partial Seizures | Potassium Blocker | III | Yes | 33% | 6 months | 2 years |
| Generalized Seizures | Potassium Blocker | III | Yes | 33% | 6 months | 2 years |
| Partial Seizures | Potassium Blocker | III | Yes | 33% | 6 months | 2 years |
Response Form
If you or a loved one is interested in participating in one of our trials, please contact us at (855) 829-8899 or use the form below. One of our skilled Clinical Research Coordinators will contact you as soon as possible. Thank you for your interest in our research!
- Stephen S. Flitman, MD, Medical Director
